Continued Investment in Enhancing Existing Products and Developing New Products to Drive Growth
First written in FY2017-Q1. 20 of 35 entries say "Restated". Latest entry: 2026-09-30.
115 other companies' latest entry also says "Advanced".
- 2026-09-30AdvancedOther Disclosures
「今回の機能強化では、設定途中でも変換テストを実行できるようにしたほか、テスト結果の確認性を向上しました。」
RACCOON V2.9.0で、画面閲覧用レイアウトの追加、変換テスト支援機能の強化、Java・OS・データベースの最新バージョン対応を実施した。 - FY2026AdvancedAnnual report
「For the existing enterprise data integration platform ACMS Apex and data handling platform RACCOON, the company reduced the processing time for small-volume, high-frequency data conversions by up to 50% based on its own measurements, and enhanced support for Web API integration and data exchange between clouds.」
For its existing products, the company reduced processing time for small-volume, high-frequency data conversions by up to 50% and enhanced support for Web API integration and data exchange between clouds. - 2026-05-13SoftenedEarnings presentation
「Development of the new products and services ACMS Cloud and Placul reached a milestone, and research and development expenses declined.」
The disclosure stated that development of ACMS Cloud and Placul had reached a milestone and that R&D expenses had decreased. - FY2026-H1RestatedAnnual report
「The Group's R&D expenditure during the interim consolidated accounting period was ¥168 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
The company recorded R&D expenditure of ¥168 million and stated that there were no material changes in the status of its R&D activities. - FY2025AdvancedAnnual report
「Total R&D expenditure for the fiscal year was ¥280 million, up 6.9% year on year, consisting mainly of personnel expenses in the R&D division and outsourced development costs. The increase from the previous fiscal year was attributable to the company's focus on developing ACMS Cloud, a cloud-based data integration platform that integrates external connectivity using EDI protocols based on ACMS Apex with links between business systems.」
R&D expenditure was ¥280 million, up 6.9% year on year, as the company focused on developing ACMS Cloud. - FY2025-H1AdvancedAnnual report
「During the interim consolidated accounting period, the first year of the medium-term management plan, the company released ACMS Apex V1.9, an enterprise data integration platform, enabling international transfers in a format compliant with the ISO 20022 international standard. It also announced the new work management platform Placul. The Group's R&D expenditure during the interim consolidated accounting period was ¥145 million.」
The company proceeded with functional enhancements to ACMS Apex V1.9 and announced Placul, recording R&D expenditure of ¥145 million. - FY2024AdvancedAnnual report
「Total R&D expenditure for the fiscal year was ¥261 million, up 10.4% year on year, consisting mainly of personnel expenses in the R&D division and outsourced development costs. Although expenditure increased from the previous fiscal year, the main reason was the company's focus on developing ACMS Cloud and Placul, which are scheduled to be offered as new services.」
R&D expenditure was ¥261 million, up 10.4% year on year, as the company focused on developing ACMS Cloud and Placul, which are scheduled to be offered. - FY2024-Q1RestatedAnnual report
「Total R&D expenditure for the three months ended the first quarter was ¥59 million. There were no material changes in the status of the company's R&D activities during the three months ended the first quarter.」
The company states that there were no material changes in its R&D activities and reports R&D expenditure of ¥59 million for the first quarter. - FY2023AdvancedAnnual report
「Total R&D expenditure for the fiscal year was ¥242 million, up 12.5% year on year, consisting mainly of personnel expenses in the R&D division and outsourced development costs. Although expenditure increased from the previous fiscal year, the main reason was the company's focus on developing the Web EDI system platform ACMS WebFramer, which supports the electronic invoicing system.」
R&D expenditure was ¥242 million, up 12.5% year on year, as the company focused on developing ACMS WebFramer to support electronic invoicing. - FY2023-Q3RestatedAnnual report
「The Group's R&D expenditure for the nine months ended the third quarter was ¥189 million, up 21.0% year on year. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」
While stating that there were no material changes in the status of its R&D activities, the company reports R&D expenditure of ¥189 million for the nine months ended the third quarter, up 21.0% year on year. - FY2023-Q2AdvancedAnnual report
「At the NP Development Office, which is responsible for creating new businesses, the company has developed product prototypes and is validating them against market needs from various perspectives, while actively developing products for new markets. The Group's R&D expenditure for the six months ended the second quarter was ¥137 million, up 36.7% year on year.」
The NP Development Office proceeded with prototyping products for new markets and validating market needs. R&D expenditure was ¥137 million, up 36.7% year on year. - FY2023-Q1AdvancedAnnual report
「During the three months ended the first quarter, the company actively expanded sales of the advanced edition for data integration platforms, which comes standard with RACCOON on ACMS Apex, and proceeded with development of the Web EDI system platform ACMS WebFramer, which supports the electronic invoicing system scheduled for launch this autumn, as well as holding seminars in preparation for its sale. The Group's R&D expenditure for the three months ended the first quarter was ¥57 million, up 17.5% year on year.」
The company proceeded with development of the new product ACMS WebFramer, and R&D expenditure increased 17.5% year on year to ¥57 million. Its policy of investing in existing and strategic products includes specific development activities and higher expenditure. - FY2022SoftenedAnnual report
「Total R&D expenditure for the fiscal year was ¥215 million, down 46.3% year on year, consisting mainly of personnel expenses in the R&D division and outsourced development costs.」
While continuing to enhance existing products and pursue new technologies, the company reports that R&D expenditure declined 46.3% year on year to ¥215 million. The decline was attributed to higher development costs resulting from the shift in development policy. - FY2022-Q3RestatedAnnual report
「In product development, the company continued to enhance and improve existing software products, while actively exploring new technologies and services, mainly through the Technology Exploration Office, and upgrading its strategic products.」
The company continues to enhance and improve existing products, explore new technologies and services, and upgrade its strategic products. R&D expenditure was ¥156 million, down 51.3% year on year. - FY2022-Q2RestatedAnnual report
「In product development, the company continued to enhance and improve existing software products, while actively pursuing new technologies through the Technology Exploration Office and upgrading its strategic products. The Group's R&D expenditure for the six months ended the second quarter was ¥100 million, down 55.0% year on year. This was due to a decrease in R&D expenditure and an increase in development costs as the company moved toward a development policy focused on improving convenience, quality and stability to promote its recurring business, while product maintenance costs increased as the products matured.」
The company continues to enhance existing products, pursue new technologies through the Technology Exploration Office, and upgrade its strategic products. R&D expenditure was ¥100 million, down 55.0% year on year, primarily due to higher development costs associated with the shift toward a development policy for the recurring business. - FY2022-Q1SoftenedAnnual report
「The Group's R&D expenditure for the three months ended the first quarter was ¥49 million, down 56.2% year on year. This was due to a decrease in R&D expenditure and an increase in development costs as the company moved toward a development policy focused on improving convenience, quality and stability to promote its recurring business, while product maintenance costs increased as the products matured.」
While continuing to enhance existing products, the company reports R&D expenditure of ¥49 million, down 56.2% year on year, as it continues to shift toward a development policy involving higher development costs. - FY2021SoftenedAnnual report
「Total R&D expenditure for the fiscal year was ¥400 million, consisting mainly of personnel expenses in the R&D division and outsourced development costs.」
The company continued to enhance the functions of existing products and ACMS Apex and implemented specific response functions. It reports that R&D expenditure decreased from ¥495 million in the previous year to ¥400 million, and expects the decrease in R&D expenditure accompanying the increase in development costs to continue. - FY2021-Q3RestatedAnnual report
「Meanwhile, in R&D, the company continued to invest in enhancements to its existing software products and strategic products, including the enterprise data integration platform ACMS Apex, while also conducting research into the latest technology trends through the newly established Technology Exploration Office.」
The company continues to invest in existing products and strategic products such as ACMS Apex, and to conduct research into the latest technology trends through the Technology Exploration Office. R&D expenditure was ¥322 million, and it states that there were no material changes in the status of its R&D activities. - FY2021-Q2RestatedAnnual report
「Meanwhile, in R&D, the company continued to invest in enhancements to its existing software products and strategic products, including the enterprise data integration platform ACMS Apex, while also conducting research into the latest technology trends through the newly established Technology Exploration Office.」
The company continues to invest in existing products and strategic products, and to conduct research into the latest technology trends through the Technology Exploration Office. R&D expenditure was ¥224 million, and it states that there were no material changes in the status of its R&D activities. - FY2021-Q1RestatedAnnual report
「Meanwhile, in R&D, the company continued to invest in enhancements to its existing software products and strategic products, including the enterprise data integration platform ACMS Apex, while also conducting research into the latest technology trends through the newly established Technology Exploration Office.」
The company continues to invest in existing products and strategic products such as ACMS Apex, and is also conducting research into the latest technology trends through the Technology Exploration Office. R&D expenditure was ¥112 million, and it states that there were no material changes in the status of its R&D activities. - FY2020AdvancedAnnual report
「Total R&D expenditure for the fiscal year was ¥495 million, consisting mainly of personnel expenses in the R&D division and outsourced development costs.」
The company recorded R&D expenditure of ¥495 million and implemented specific functional enhancements for its strategic products, including ACMS Apex's communications protocols, Web API, clustering functions, and support for operating systems, Java and databases. - FY2020-Q3RestatedAnnual report
「• In light of the creation of and entry into new markets in the future, strengthen R&D investment and the technology exploration framework. (4) Research and Development Activities The Group's R&D expenditure for the nine months ended the third quarter was ¥375 million. There were no material changes in the status of the Group's R&D activities during the nine months ended the third quarter.」
The company continues its policy of strengthening R&D investment and the technology exploration framework with a view to future new markets, and reports R&D expenditure of ¥375 million. It states that there were no material changes in the status of its R&D activities. - FY2020-Q2RestatedAnnual report
「• In light of the creation of and entry into new markets in the future, strengthen R&D investment and the technology exploration framework. (5) Research and Development Activities The Group's R&D expenditure for the six months ended the second quarter was ¥241 million. There were no material changes in the status of the Group's R&D activities during the six months ended the second quarter.」
The company continues its policy of strengthening R&D investment and the technology exploration framework with a view to future new markets, and reports R&D expenditure of ¥241 million. It states that there were no material changes in the status of its R&D activities. - FY2020-Q1RestatedAnnual report
「・Strengthen R&D investment and the technology exploration structure with a view to creating and entering new markets in the future (4) Research and Development Activities The Group’s total R&D activities during the first quarter of the fiscal year amounted to ¥120 million.」
The company continues its policy of strengthening R&D investment and the technology exploration structure with a view to future new markets, and reported R&D activities of ¥120 million for the quarter. - FY2019AdvancedAnnual report
「Total R&D expenses for the fiscal year amounted to ¥490 million, consisting mainly of personnel expenses in the R&D division and outsourced development costs.」
The company recorded R&D expenses of ¥490 million and implemented functions including Zengin EDI connectivity, license keys, communication protocols, and an IBM MQ adapter for ACMS Apex. - FY2019-Q3RestatedAnnual report
「In addition to continuing R&D investment in enhancing the functionality of existing software products and in strategic products that will drive future corporate growth, including the enterprise data integration platform ACMS Apex, we invested in establishing an organizational structure to address quality improvement needs and in strengthening support services following product sales expansion. The Group’s total R&D activities during the first nine months of the fiscal year amounted to ¥366 million.」
The company continued R&D investment in enhancing existing products and in strategic products such as ACMS Apex, and reported R&D activities of ¥366 million. - FY2019-Q2RestatedAnnual report
「In addition to continuing R&D investment in enhancing the functionality of existing software products and in strategic products that will drive future corporate growth, including the enterprise data integration platform ACMS Apex, we invested in establishing an organizational structure to address quality improvement needs and in strengthening support services following product sales expansion.」
The company continued R&D investment in existing products and strategic products such as ACMS Apex, with R&D activities during the first six months of the fiscal year amounting to ¥231 million. The establishment of an organizational structure to address quality improvement needs and the strengthening of post-sales support are recorded as new measures in a separate thread. - FY2019-Q1RestatedAnnual report
「In research and development, we continued to invest in enhancing the functionality of existing software products and in strategic products that will drive future corporate growth, including the enterprise data integration platform ACMS Apex. The Group’s total R&D activities during the first quarter of the fiscal year amounted to ¥111 million.」
The company reaffirmed its continued investment in enhancing existing products and in strategic products such as ACMS Apex, and reported R&D activities of ¥111 million. - FY2018RestatedAnnual report
「In research and development, we continued to invest in enhancing the functionality of existing software products and in strategic products that will drive future corporate growth, including the enterprise data integration platform ACMS Apex.」
The company reaffirmed its continued investment in enhancing existing products and in strategic products such as ACMS Apex. R&D expenses were ¥515 million, and the company also described functionality enhancements for security, cloud, and database support across its products. - FY2018-Q3RestatedAnnual report
「In research and development, we continued to invest in enhancing the functionality of existing software products and in strategic products that will drive future corporate growth, including the enterprise data integration platform ACMS Apex. The Group’s total R&D activities during the first nine months of the fiscal year amounted to ¥386 million.」
The company reaffirmed its continued investment in enhancing existing products and in strategic products such as ACMS Apex, and reported R&D activities of ¥386 million. - FY2018-Q2RestatedAnnual report
「In research and development, we continued to invest in enhancing the functionality of existing software products and in strategic products that will drive future corporate growth, including the enterprise data integration platform ACMS Apex. The Group’s total R&D activities during the first six months of the fiscal year amounted to ¥262 million.」
The company reaffirmed its continued investment in enhancing existing products and in strategic products such as ACMS Apex, and reported R&D activities of ¥262 million. - FY2018-Q1RestatedAnnual report
「In research and development, we continued to invest in enhancing the functionality of existing software products and in strategic products that will drive future corporate growth, including the enterprise data integration platform ACMS Apex. The Group’s total R&D activities during the first quarter of the fiscal year amounted to ¥126 million.」
The company reaffirmed its continued investment in enhancing existing products and in strategic products such as ACMS Apex, and reported R&D activities of ¥126 million. - FY2017-Q3RestatedAnnual report
「In research and development, we continued to invest in enhancing the functionality of existing software products and in new products that will drive future corporate growth, including the enterprise data integration platform ACMS Apex, which we began selling in June 2016. The Group’s total R&D activities during the first nine months of the fiscal year amounted to ¥396 million. There were no material changes in the status of the Group’s R&D activities during the first nine months of the fiscal year.」
The company reaffirmed its continued investment in enhancing existing products and in new products such as ACMS Apex, and reported R&D activities of ¥396 million. - FY2017-Q2RestatedAnnual report
「In research and development, we continued to invest in enhancing the functionality of existing software products and in new products that will drive future corporate growth, including the enterprise data integration platform ACMS Apex, which we began selling in June 2016.」
The company reaffirmed its continued investment in enhancing existing products and in new products, including ACMS Apex. - FY2017-Q1First statedAnnual report
「In research and development, we continued to invest in enhancing the functionality of existing software products and in new products that will drive future corporate growth, including ACMS WebFramer and RACCOON,」
The company explicitly identifies R&D investment in both existing and new products.